Vaccine News and Research

Latest Vaccine News and Research

Accelerated regime of preventative drugs could prevent malaria infection and deaths in Africa

Malaria infection and deaths could be avoided by more than half a million young children thanks to an accelerated regime of preventative drugs being rolled in four African countries, says global health agency Unitaid.

18 Oct 2021

Delta and Delta Plus infect lung cells with higher efficiency than the original virus, research shows

The emergence of new SARS-CoV-2 variants that can spread rapidly and undermine vaccine-induced immunity threatens the end of the COVID-19 pandemic. The delta variant (B.1.617.2) emerged in India and subsequently spread globally within a short time period. Also in Germany, almost all recent infections are due to this variant.

18 Oct 2021

Serologic testing algorithm to detect disparities in SARS-CoV-2 infection prevalence and vaccination uptake

A new study recently published on the medRxiv* preprint server demonstrates the use of a serological testing algorithm for identifying disparities in infection rates and vaccine uptake amongst the study population to enable public health interventions.

17 Oct 2021

Mix-and-match booster shots beneficial in boosting SARS-CoV-2 immunity

Should you get a second dose of the same vaccine if you’ve received the one-dose Johnson & Johnson shot? According to new clinical trial results published on the preprint medRxiv* server, a booster shot of a messenger RNA (mRNA) vaccine may increase your chances of neutralizing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

17 Oct 2021

Researchers identify common side effects of three COVID-19 vaccines

COVID-19 vaccines remain the best tool in the pandemic toolbox against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). But they are not perfect; reports have surfaced of mild to severe side effects after vaccination. A new study from researchers in the Lampe & Company GmbH & Co. KG compared the severity of adverse events from each coronavirus vaccine.

17 Oct 2021

Phase 1 open-label trial shows SARS-CoV-2 DNA vaccine induces durable immune response

The efficacy and safety of a DNA-based vaccine are investigated, finding that the unique vaccine imparts a robust and long-lasting immunogenic response.

15 Oct 2021

Phase 2 study shows safety and immunogenicity of SARS-CoV-2 recombinant protein vaccine

The results of a phase 2 clinical trial featuring a SARS-CoV-2 recombinant protein vaccine developed by GlaxoSmithKline are reported, demonstrating a favorable immune response amongst both naïve and non-naïve adults with an acceptable safety profile.

15 Oct 2021

Study finds menstrual bleeding changes after SARS-CoV-2 vaccination

A new study investigated menstrual bleeding patterns among current and former menstruating people, based on the premise that these bleeding changes were associated with changes in clotting or inflammation, which can affect the normal menstrual repair.

15 Oct 2021

New program could be added to the COVID alert app to improve vaccination campaigns

Researchers are developing a program that could be added to the COVID alert app used on smartphones to better target vaccination campaigns.

15 Oct 2021

Scientists testify the importance of timely influenza vaccination

With flu season approaching in the United States, new research from an international team of scientists testifies to the importance of timely vaccination

15 Oct 2021

Cell-based quadrivalent influenza vaccine produces sufficient immune response in children

A cell-based influenza vaccine has effectively provided protection against the flu in children and adolescents, according to a new study.

15 Oct 2021

Eligible fully vaccinated passengers arriving in England can take a cheaper lateral flow test

Eligible fully vaccinated passengers arriving in England from countries not on the red list can take a lateral flow test on or before day 2 of their arrival from October 24, rather than PCR tests - cutting the cost of tests in time for travelers returning from half term breaks.

14 Oct 2021

SARS-CoV-2 outbreak in Delhi highlights challenge of reaching herd immunity against Delta

The severe outbreak of COVID-19 in Delhi, India, in 2021 showed not only that the Delta variant of SARS-CoV2 is extremely transmissible but that it can infect individuals previously infected by a different variant of the coronavirus, say a team of international scientists writing in Science.

14 Oct 2021

Vaccine News and Research

Latest Vaccine News and Research

Accelerated regime of preventative drugs could prevent malaria infection and deaths in Africa

Delta and Delta Plus infect lung cells with higher efficiency than the original virus, research shows

Serologic testing algorithm to detect disparities in SARS-CoV-2 infection prevalence and vaccination uptake

Mix-and-match booster shots beneficial in boosting SARS-CoV-2 immunity

Researchers identify common side effects of three COVID-19 vaccines

Phase 1 open-label trial shows SARS-CoV-2 DNA vaccine induces durable immune response

Phase 2 study shows safety and immunogenicity of SARS-CoV-2 recombinant protein vaccine

Study finds menstrual bleeding changes after SARS-CoV-2 vaccination

New program could be added to the COVID alert app to improve vaccination campaigns

Scientists testify the importance of timely influenza vaccination

Cell-based quadrivalent influenza vaccine produces sufficient immune response in children

Eligible fully vaccinated passengers arriving in England can take a cheaper lateral flow test

SARS-CoV-2 outbreak in Delhi highlights challenge of reaching herd immunity against Delta

Race Disparity Unit wins a Research Excellence Award from ONS

KHN’s ‘What the Health?’: The politics of vaccine mandates

COVID-19 immunity in family members reduces risk of infection by 45-97%

Increased transmission in open spike conformations of SARS-CoV-2 variants

Mutation of cysteine residues in NRP1 reduces SARS-CoV-2 spike protein entry into cells

Improving COVID-19 vaccinations through contact-tracing apps

Assay for the sensitive and specific identification of SARS-CoV-2 Delta variant

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Newsletters you may be interested in